NeuroSense Therapeutics L... (NRSNW)

AI Score

Unlock

0.26

0.06 (32.79%)

At close: Apr 17, 2025, 12:47 PM

0.26

0.00%

After-hours: Apr 17, 2025, 04:00 PM EDT

NeuroSense Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is undefined.

Fiscal Year	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021	Q4 2020	Q3 2020	Q2 2020	Q1 2020
Period Ending	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020
Net Income	-2.15K	-857	-5.4K	-1.78K	784.00	-5.22K	-3.89K	-1.3K	-2.99K	-3.48K	-2.71K	-101	-888	-928	-2.12K	-1.1K	-1.1K	-311	-311
Depreciation & Amortization	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	1.50	1.50	n/a	n/a
Stock-Based Compensation	-306	306.00	n/a	1.54K	-1.78K	1.78K	n/a	1.73K	-2.81K	2.81K	n/a	3.82K	-2.63K	2.63K	n/a	907.00	907.00	123.50	123.50
Other Working Capital	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	19.50	19.50	6.00	6.00
Other Non-Cash Items	2.45K	551.00	5.4K	240.00	1K	3.44K	3.89K	-426	5.8K	673.00	2.71K	-3.72K	3.52K	-1.7K	2.12K	3.50	3.50	11.50	11.50
Deferred Income Tax	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Change in Working Capital	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	21.00	21.00	-1.5	-1.5
Operating Cash Flow	n/a	n/a	n/a	n/a	n/a	1.78K	n/a	5.11K	-2.81K	2.81K	n/a	n/a	n/a	n/a	n/a	-170	-170	-177.5	-177.5
Capital Expenditures	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	-2.5	-2.5	-2	-2
Cash Acquisitions	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Purchase of Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Sales Maturities Of Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Investing Acitivies	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Investing Cash Flow	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	-2.5	-2.5	-2	-2
Debt Repayment	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Common Stock Repurchased	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	n/a	n/a	n/a	n/a	n/a	n/a	n/a	3.69M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	254.00	254.00
Financial Cash Flow	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	254.00	254.00
Net Cash Flow	n/a	n/a	n/a	n/a	-2.33M	5.73M	-2.18M	-855K	62K	2.81K	n/a	n/a	n/a	n/a	n/a	-172.5	-172.5	74.50	74.50
Free Cash Flow	n/a	n/a	n/a	n/a	n/a	1.78K	n/a	5.11K	-2.81K	2.81K	n/a	n/a	n/a	n/a	n/a	-172.5	-172.5	-179.5	-179.5